Abstract: Objective To analyze the isolation, identification and drug sensitivity of Gordonia bronchialis in tumor patients with catheter related bloodstream infection, and provide reference for clinical treatment of infectious diseases caused by this bacteria. Method The blood culture positive sample was collected from a patient with endometrial cancer after radiotherapy, which was collected through venous catheter and peripheral vein. At the same time, the isolate was identified and analyzed by using VITEK MS fully automated microbial mass spectrometry detection system and molecular sequencing technology, and the drug sensitivity tests were conducted according to the Gram positive rod bacteria drug sensitivity test standards. Result After incubating the venous catheter blood and peripheral venous blood for 48 hours, a positive alarm was reported, and Gram positive bacteria were found on the smear. Cultivated on a blood agar plate for 24 hours, it grew non hemolytic bacterial colonies which were white,rough and dry. After 48 hours of cultivation, the white ,roug hand dry bacterial colonies transformed into orange, rough and dry bacterial colonies. The VITEK MS mass spectrometer and 16S rRNA sequencing technology both identified that this bacterium was Gordon bronchialis, and the drug sensitivity results showed that this bacterium was sensitive to vancomycin, ceftriaxone, cefepime, ciprofloxacin, imipenem, meropenem, linezolid, and compound sulfamethoxazole. Conclusion This study reports the biological characteristics and diagnosis and treatment process of Gordonia bronchialis. Although this bacterium is common in the environment, there are relatively few cases related to human diseases. Like all microbial infections, timely diagnosis and treatment should be carried out for suspected or confirmed Gordonia bronchialis's infection.
A case of catheter related bloodstream infection in a tumor patient caused by Gordonia bronchialis[J]. Journal of Microbes and Infections. 2024, 19(3): 162-168